Post Partum Hemorrhage Clinical Trial
Official title:
Amniotomy and Early Oxytocin Infusion Versus Amniotomy and Delayed Oxytocin Infusion in Nulliparous Women: a Randomised Controlled Trial
In UKM Medical Centre (UKMMC), delayed oxytocin augmentation at two hours following amniotomy
is the routine obstetric practice in spontaneous or induced labour with intact membranes.
This practice may potentially cause prolonged labour, extended labour room occupancy and
increased maternal exhaustion while no additional benefit can be gained. On the other hand,
recommendation for early oxytocin augmentation poses a dilemma as the effectiveness and
safety of this practice are still in doubt.
Given this background, the aim of this study was to compare the effect of early versus delay
oxytocin infusion in achieving successful vaginal delivery among the low-risk nulliparous
women in UKMMC. Besides, this study also compares the adverse maternal and neonatal outcomes
between the two practices.
This was a randomised controlled trial undertaken in the labour room of UKMMC for a period of
eighteen months from August 2014 until February 2016. Eligible women who were admitted in
spontaneous labour or for induction of labour were recruited. For women who underwent
induction of labour, an interval of at least six hours following vaginal prostaglandin before
recruitment was mandatory to avoid overlapping effect of prostaglandin and oxytocin. Upon
enrolment, each patient was given a study explanation and written consent was obtained.
The randomisation sequence, either to the early oxytocin group or the delayed oxytocin group,
was generated using the computer randomisation program in block of two. Allocation to either
arm of treatment was determined by the sequential opening of sealed numbered envelopes.
In the first arm of early oxytocin group, labour augmentation with oxytocin was started early
following artificial ruptured of membrane(ARM). In the second arm of delayed oxytocin group,
oxytocin augmentation was delayed at two hours after ARM and this practice is currently being
used as standard protocol in this hospital to manage women in labour. In both arms,the
infusion rate was doubled every 30 minutes to a maximum of 48 mL/h or until four to five
moderate contractions per 10 minutes were achieved at which point the infusion rate was
maintained. Continuous fetal heart rate monitoring was maintained throughout the intrapartum
period. Vaginal examination was performed at four hours after ARM as well as when clinically
indicated ie. abnormal cardiotocography (CTG) and maternal desire to bear down. In the
presence of abnormal CTG, either fetal blood sampling or expedited delivery was undertaken as
per decided by the obstetrician in charge.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03680339 -
The Effect of Preoperative and Post Operative Misoprostol Administration on Intraoperative Blood Loss and Postpartum Hemorrhage in CS
|
Phase 4 | |
Completed |
NCT03693599 -
Carbetocin Versus Syntometrine in Obese Women Undergoing Elective Cesarean
|
Phase 4 | |
Completed |
NCT03707132 -
Tourniquet Reduces Blood Loss in Postpartum Hemorrhage During Hysterectomy for Placenta Accreta
|
||
Recruiting |
NCT02306733 -
Ergometrine Versus Oxytocin in the Management of Atonic Post-partum Haemorrhage (PPH) in Women Delivered Vaginally
|
Phase 3 | |
Completed |
NCT01866241 -
Combating Maternal Mortality in Uganda: An Assessment of the Role of Misoprostol in Prevention of Post-Partum Hemorrhage
|
Phase 3 | |
Not yet recruiting |
NCT01236482 -
Oxytocin in Cesarean Delivery
|
Phase 4 | |
Completed |
NCT03784794 -
Patient Blood Management for Massive Obstetric Hemorrhage
|
N/A | |
Enrolling by invitation |
NCT06255496 -
QStat Cartridge in Obstetric Patients
|
||
Recruiting |
NCT04401839 -
Amr Maneuver for Prevention of Postpartum Hemorrhage
|
N/A | |
Recruiting |
NCT06219538 -
DAISY Uterine Drain Device Evaluation
|
N/A | |
Not yet recruiting |
NCT06333340 -
Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery
|
N/A | |
Completed |
NCT01863706 -
Misoprostol Versus Oxytocin for Prevention of Post Partum Hemorrhage
|
Phase 1 | |
Completed |
NCT04723979 -
NovoSeven® in Severe Postpartum Haemorrhage - Experiences From UK, DK, FR, NL
|
||
Terminated |
NCT04277962 -
Estimating Blood Loss Using TritonTM in Vaginal Deliveries: A Validation Trial
|
N/A | |
Completed |
NCT03570723 -
Glove-loaded Foley's Catheter Tamponade for Cesarean Section for Placenta Previa
|
N/A | |
Completed |
NCT03117647 -
Mansoura-VV Uterine Compression Suture for Primary Atonic Postpartum Hemorrhage
|
N/A | |
Active, not recruiting |
NCT03069859 -
Use of TXA to Prevent Postpartum Hemorrhage
|
Phase 2 | |
Not yet recruiting |
NCT03891082 -
A Comparative Study Between Bakri Balloon and B Lynch Suture Used to Control Primary Postpartum Hemorrhage After Cesarean Section
|
N/A | |
Not yet recruiting |
NCT03463070 -
Misoprostol Before and After Cesarean Section
|
Phase 3 | |
Recruiting |
NCT05532215 -
Sublingual Misoprostol in Reduction of Caesarean Blood Loss
|
N/A |